Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy. - Smyth P; Ferguson L; Burrows JF; Burden RE; Tracey SR; Herron ÚM; Kovaleva M; Williams R; Porter AJ; Longley DB; Barelle CJ; Scott CJ (Frontiers in pharmacology, 2023)